GKOS

Glaukos Corporation

89.57 USD
0.00 (0.00%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Glaukos Corporation stock is down -3.19% since 30 days ago. The next earnings date is May 1, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 77.78% of the previous 8 February’s closed higher than January. In the last 10 Unusual Options Trades, there were 2 CALLs, 8 PUTs. 100% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
09 Jan 20:47 19 Jan, 2024 65.00 CALL 12 426
30 Jan 17:21 15 Mar, 2024 85.00 PUT 100 112
20 Feb 20:48 15 Mar, 2024 92.50 PUT 50 15
20 Feb 20:49 19 Apr, 2024 92.50 PUT 76 18
21 Feb 16:35 15 Mar, 2024 100.00 PUT 50 23
21 Feb 16:36 15 Mar, 2024 100.00 PUT 50 23
22 Feb 15:18 15 Mar, 2024 92.50 CALL 83 114
22 Feb 15:35 15 Mar, 2024 85.00 PUT 294 820
22 Feb 15:48 15 Mar, 2024 92.50 PUT 108 708
23 Feb 16:33 15 Mar, 2024 100.00 PUT 59 109

About Glaukos Corporation

Glaukos Corporation focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. The company markets its products through direct sales organization, as well as through distributors in the United States and internationally.

  • Wells Fargo
    Thu Feb 22, 11:20
    buy
    confirm
  • Needham
    Thu Feb 22, 05:37
    buy
    confirm
  • Needham
    Fri Feb 16, 05:17
    buy
    confirm